Literature DB >> 26701273

The Impact of Visual Field Clusters on Performance-based Measures and Vision-Related Quality of Life in Patients With Glaucoma.

Yi Sun1, Clarissa Lin1, Michael Waisbourd1, Feyzahan Ekici1, Elif Erdem1, Sheryl S Wizov1, Lisa A Hark1, George L Spaeth2.   

Abstract

PURPOSE: To investigate how visual field (VF) clusters affect performance-based measures of the ability to perform activities of daily living and subjective measures of vision-related quality of life (QoL) in patients with glaucoma.
DESIGN: Prospective, cross-sectional study.
METHODS: setting: Institutional - Wills Eye Hospital. STUDY POPULATION: 322 eyes of 161 patients with moderate-stage glaucoma. OBSERVATION: VF tests were conducted using the Humphrey 24-2 Swedish Interactive Thresholding Algorithm standard perimeter. The VFs of each patient were divided into 5 clusters: nasal, temporal, central, paracentral, and peripheral. The score for each cluster was the averaged total deviation scores of all tested points within the cluster. Each cluster score was correlated with performance-based measures of visual function and subjective assessment of vision-related QoL. MAIN OUTCOME MEASURES: The Compressed Assessment of Ability Related to Vision, the National Eye Institute Visual Functioning Questionnaire 25 (NEI VFQ-25), and the Modified Glaucoma Symptom Scale.
RESULTS: The central VF cluster in the better eye was positively correlated with all Compressed Assessment of Ability Related to Vision (performance-based measure) subscales. The strongest correlation for the better eye was between the central VF cluster and total Compressed Assessment of Ability Related to Vision score (0.39, P < .001). The inferior VF hemisphere in both eyes was positively correlated with most Compressed Assessment of Ability Related to Vision subscales. Central VF clusters in the better eye were positively correlated with a majority of the NEI VFQ-25 subscales. There were no significant correlations between VF clusters and Modified Glaucoma Symptom Scale subscales.
CONCLUSIONS: Scores of central VF defects in the better eye and inferior hemisphere defects in both eyes were positively correlated with performance-based measures of the ability to perform activities of daily living. Glaucoma patients with central defects in the better eye were more likely to have reduced scores on assessments of vision-related QoL.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26701273     DOI: 10.1016/j.ajo.2015.12.006

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  19 in total

1.  Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss.

Authors:  Aakriti Garg; C Gustavo De Moraes; George A Cioffi; Christopher A Girkin; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill; Jeffrey M Liebmann
Journal:  Am J Ophthalmol       Date:  2018-01-06       Impact factor: 5.258

2.  Seeing other perspectives: evaluating the use of virtual and augmented reality to simulate visual impairments (OpenVisSim).

Authors:  Pete R Jones; Tamás Somoskeöy; Hugo Chow-Wing-Bom; David P Crabb
Journal:  NPJ Digit Med       Date:  2020-03-10

3.  Performance of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma.

Authors:  Zhichao Wu; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill
Journal:  Am J Ophthalmol       Date:  2018-08-10       Impact factor: 5.258

4.  Comparing 10-2 and 24-2 Visual Fields for Detecting Progressive Central Visual Loss in Glaucoma Eyes with Early Central Abnormalities.

Authors:  Zhichao Wu; Felipe A Medeiros; Robert N Weinreb; Christopher A Girkin; Linda M Zangwill
Journal:  Ophthalmol Glaucoma       Date:  2019-01-14

5.  Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients.

Authors:  Adriano Guarnieri; Elena Carnero; Anne-Marie Bleau; Belén Alfonso-Bartolozzi; Javier Moreno-Montañés
Journal:  Int Ophthalmol       Date:  2019-12-07       Impact factor: 2.031

6.  Association Between Undetected 10-2 Visual Field Damage and Vision-Related Quality of Life in Patients With Glaucoma.

Authors:  Dana M Blumberg; Carlos Gustavo De Moraes; Alisa J Prager; Qi Yu; Lama Al-Aswad; George A Cioffi; Jeffrey M Liebmann; Donald C Hood
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

7.  Association of Visual Field Pattern Reversal with Paracentral Visual Field Loss.

Authors:  Aimee C Chang; Andrew S Camp; Vincent M Patella; Robert N Weinreb
Journal:  Ophthalmol Glaucoma       Date:  2021-10-21

Review 8.  A Review of Studies of the Association of Vision-Related Quality of Life with Measures of Visual Function and Structure in Patients with Glaucoma in the United States.

Authors:  Naira Khachatryan; Maxwell Pistilli; Maureen G Maguire; Angela Y Chang; Marissa R Samuels; Kristen Mulvihill; Rebecca J Salowe; Joan M O'Brien
Journal:  Ophthalmic Epidemiol       Date:  2021-02-03

9.  Qualitative Evaluation of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma.

Authors:  Adi Orbach; Ghee Soon Ang; Andrew S Camp; Derek S Welsbie; Felipe A Medeiros; Christopher A Girkin; Massimo A Fazio; Won Hyuk Oh; Robert N Weinreb; Linda M Zangwill; Zhichao Wu
Journal:  Am J Ophthalmol       Date:  2021-02-21       Impact factor: 5.488

10.  Simplified automatic method for measuring the visual field using the perimeter ZERK 1.

Authors:  Robert Koprowski; Paweł Kasprowski; Marek Rzendkowski
Journal:  Biomed Eng Online       Date:  2016-07-25       Impact factor: 2.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.